Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Study Shows Nasal Powder Epinephrine Provides Superior Stability to EpiPens
Needle-free, nasal delivery of epinephrine has been shown to be an effective and stable treatment for anaphylaxis. MILWAUKEE, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Nasal powder formulations of epinephrine demonstrated superior stability and comparable plasma exposure to EpiPens according to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 12, 2024 Category: Pharmaceuticals Tags: SVY TRI FVT Source Type: news

Death of a child due to venom toxicity following multiple honey bee stings: a case report - Singh BK, Sharma M, Lra SP, Chauhan M.
Most bee stings are not life-threatening. Bee venom often causes local, mild allergic reactions in people, but even a single bee sting may induce a fatal anaphylactic reaction. Usually, anaphylactic reaction is the cause of death, but, when a child suffers... (Source: SafetyLit)
Source: SafetyLit - February 12, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Acid-Suppressive Medication and Antimicrobial Use in Infancy Associated with Food Allergy and Anaphylaxis
New research shows infants exposed to acid-suppressive medication had nearly a 6-fold increased risk of food allergy MILWAUKEE, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Patients who were prescribed proton pump inhibitors (PPIs) in infancy demonstrated increased food allergy risk, according to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 6, 2024 Category: Pharmaceuticals Tags: SVY TRI Source Type: news

Clinical Challenges: Anaphylaxis and Epinephrine
(MedPage Today) -- Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and 150 deaths each year. While... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 31, 2024 Category: Allergy & Immunology Source Type: news

Dancer Órla Baxendale’s Final Moments Revealed Before Eating Cookie That Killed Her
New details are emerging about Órla Baxendale's final moments. The New York dancer, who died Jan. 11 at age 25, took precautions to prevent her death, according to her family attorney. At a social gathering earlier this month, Baxendale went into anaphylactic shock due to a severe allergic…#órlabaxendale #baxendale #becauseorla #marijoadimey #abcnews #stewleonard #epipen (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news

NYC Dancer, 25, Dead After Eating Mislabeled Cookies With Peanuts
rla Baxendale joined a dance company in Connecticut after earning her stripes in Manhattan, according to NBC Connecticut. Baxendale reportedly went into anaphylactic shock at a social gathering in Connecticut after eating cookies purchased at Stew Leonards. "For someone to leave us so young and so…#rlabaxendale #connecticut #manhattan #nbcconnecticut #stewleonards #guillermoasca #orlabaxendale #aileyschoolofdance #stewleonard #cookiesunited (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news

Anaphylaxis as probable cause of death in a rare case of fatal Vipera berus bite - Mittendorf AF, Winskog C.
This case report describes the death of a 52-year-old male who was bitten by a venomous snake, Vipera berus (common European adder), on his left wrist. Despite experiencing symptoms, the patient refused medical care and self-medicated with alcohol instead.... (Source: SafetyLit)
Source: SafetyLit - January 26, 2024 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

Allergy Alert: What Could New Guidelines on Anaphylaxis Mean for You?
TUESDAY, Jan. 23, 2024 -- If you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis, management and treatment of anaphylaxis.The latest... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 23, 2024 Category: General Medicine Source Type: news

Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure
FRIDAY, Jan. 19, 2024 -- Prenatal opioid exposure (POE) is associated with an increased risk for infection, eczema and dermatitis, and asthma in offspring, but it is not linked to allergies or anaphylaxis, according to a study published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2024 Category: Pharmaceuticals Source Type: news

University of Chicago Study Determines Certain Gut Bacteria Can Help Prevent Food Allergies and Other Gastrointestinal Illnesses
With further research, clinical laboratories may soon be performing macrobiotic testing to measure certain bacterial levels in patients’ gut bacteria New insights from the University of Chicago (UChicago) into how human microbiota (aka, gut bacteria) play a role in food allergies has the potential to change the way a number of gastrointestinal health conditions are […] The post University of Chicago Study Determines Certain Gut Bacteria Can Help Prevent Food Allergies and Other Gastrointestinal Illnesses appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - January 19, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine anaphylactic response anatomic pathology antigen Asthma and Allergy Foundation of America butyrate Cathryn Nagler PhD circulatory system Source Type: news

North Carolina firm joins push to create EpiPen alternatives
A Triangle-based startup is aiming to develop an alternative to existing treatments for anaphylaxis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 8, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

Updated Guidelines Issued for Management of Anaphylaxis
TUESDAY, Dec. 26, 2023 -- In a practice parameter update published online Dec. 17 in the Annals of Allergy, Asthma& Immunology, new guidelines are presented for the diagnosis and management of anaphylaxis. David B. K. Golden, M.D.C.M., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 26, 2023 Category: Pharmaceuticals Source Type: news